Adjunctive Dietary Supplements in Psychiatry: What Does the Evidence Support?

Dates and Times

Start: 4/29/2026 1:00 PM
End: 4/29/2026 2:00 PM

Objectives

-Identify the dietary supplements with the strongest evidence base for adjunctive use in the treatment of major depressive disorder.
-Evaluate the quality and limitations of the current evidence supporting adjunctive dietary supplements in depression.
-Compare the efficacy, tolerability, and safety profiles of dietary supplements when used as adjunctive therapy with standard antidepressants.
-Apply practical clinical considerations — including dosing, drug interactions, product selection, and cost — when discussing adjunctive dietary supplements in psychiatric patients with depression.
-Learn appropriate wasy to counsel patients on the appropriate role of dietary supplements within a comprehensive treatment plan.

Speakers

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.